130 related articles for article (PubMed ID: 11995703)
21. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
Kalofonos HP; Kardamakis D; Bamias A; Skarlos D; Papakostas P; Bafaloukos D; Sakantamis A; Pavlidis N; Fountzilas G
Anticancer Res; 2003; 23(2C):1687-91. PubMed ID: 12820441
[TBL] [Abstract][Full Text] [Related]
23. [Colorectal carcinoma].
Schulthess G; Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2005 Nov; 94(44):1705-11; quiz 1712. PubMed ID: 16309014
[No Abstract] [Full Text] [Related]
24. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
[TBL] [Abstract][Full Text] [Related]
25. Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin.
Rosenthal DI; Haller DG; Saltz L; Semple D; Minsky BD
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):59-62. PubMed ID: 11098496
[TBL] [Abstract][Full Text] [Related]
26. [Advance in preoperative radiochemotherapy for resectable rectal cancer].
Chen YH; Li ZP
Ai Zheng; 2008 Dec; 27(12):1341-4. PubMed ID: 19080006
[TBL] [Abstract][Full Text] [Related]
27. Surgical adjuvant therapy for rectal cancer: present options.
Papillon J
Dis Colon Rectum; 1994 Feb; 37(2):144-8. PubMed ID: 8306834
[TBL] [Abstract][Full Text] [Related]
28. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials.
Bujko K; Glynne-Jones R; Bujko M
Ann Oncol; 2010 Sep; 21(9):1743-1750. PubMed ID: 20231300
[TBL] [Abstract][Full Text] [Related]
29. Preoperative concomitant radiochemotherapy and IORT in locally advanced rectal cancer.
Crucitti F; Sofo L; Ratto C; Battista Doglietto G; Bellantone R; Nucera P; Bossola M; Ranieri R; Perilli W; Azario L
Rays; 1995; 20(2):197-207. PubMed ID: 7480868
[TBL] [Abstract][Full Text] [Related]
30. Postoperative adjuvant radio(chemo)therapy for rectal cancer: an appraisal.
Scandolaro L; Cazzaniga LF; Bianchi E; Cagna E; Prina M; Valli MC; Barsacchi L; Frigerio M
Tumori; 2004; 90(2):208-15. PubMed ID: 15237584
[TBL] [Abstract][Full Text] [Related]
31. Combined-modality therapy of rectal cancer with irinotecan-based regimens.
Minsky BD
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):49-55. PubMed ID: 15685836
[TBL] [Abstract][Full Text] [Related]
32. [Radiochemotherapy of rectal tumors].
Arcangeli G
Tumori; 2001; 87(1 Suppl 1):S5-6. PubMed ID: 11300024
[No Abstract] [Full Text] [Related]
33. [Chemotherapy and rectal cancer].
Michel P; Di Fiore F
Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
[TBL] [Abstract][Full Text] [Related]
34. [Principles of postoperative therapy in rectal carcinoma].
Folprecht G; Köhne CH
Chirurg; 2004 Jan; 75(1):32-7. PubMed ID: 14740125
[TBL] [Abstract][Full Text] [Related]
35. [Neoadjuvant radiochemotherapy for rectal cancer].
Zehentmayr F; Wolf M; Weissenborn Y; Feldmann HJ; Belka C
MMW Fortschr Med; 2011 Sep; 153(35):31-3. PubMed ID: 21916302
[No Abstract] [Full Text] [Related]
36. A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.
Kalofonos HP; Bamias A; Koutras A; Papakostas P; Basdanis G; Samantas E; Karina M; Misailidou D; Pisanidis N; Pentheroudakis G; Economopoulos T; Papadimitriou C; Skarlos DV; Pectasides D; Stavropoulos M; Bafaloukos D; Kardamakis D; Karanikiotis C; Vourli G; Fountzilas G;
Eur J Cancer; 2008 Aug; 44(12):1693-700. PubMed ID: 18639450
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
[TBL] [Abstract][Full Text] [Related]
38. [Rectal carcinoma. Optimizing treatment by neoadjuvant and adjuvant therapy?].
Fasolini F
Zentralbl Chir; 1999; 124(5):441-5. PubMed ID: 10420532
[TBL] [Abstract][Full Text] [Related]
39. [Chemoradiation for rectal cancer].
Koyanagi Y; Katoh K; Satoh S
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2078-83. PubMed ID: 9388516
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy of colorectal cancer.
Kemeny N; Saltz L; Cohen A
Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
